COSTAR Lung 213410 Prior Anti-Pd-(L)1 Therapy with Platinum Chemotherapy
People with Non-Small Cell Lung Cancer are asked to participate in a GlaxoSmithKline research study being conducted by White Plains Hospital.
You may be eligible to participate in this study if you:
• Are a male or female ≥18 years of age
• Have histologically or cytologically proven advanced or metastatic NSCLC
• Have received no more than 2 prior lines of therapy
• Have adequate organ function
You may NOT participate in this study if you:
• Have received investigational treatment in another clinical study within the past 4 weeks
• Have received radiation to the lung in the last 6 months
• Have known immunodeficiency virus (HIV) infection, hepatitis B or C
• Have current interstitial lung disease, current pneumonitis,
• Have received a live vaccine in the last 30 days
• Are pregnant or breastfeeding
Contact Information
Hyemin Kim, Study Coordinator
2 Longview Avenue
White Plains, New York 10601
Phone: (914) 849-7591
Email: hkim3@wphospital.org